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Background: Many proteins are subject to 
posttranslational regulation, such as ubiquitination. 
Results: Human DNA polymerase ι (polι) can be 
monoubiquitinated at >27 unique sites and 
exposure to naphthoquinones results in 
polyubiquitination of polι. 
Conclusion: Ubiquitination sites are located 
across the entire polι polypeptide, as well as 
various structural motifs. 
Significance: Ubiquitination at these sites are 
likely to alter polι’s cellular functions in vivo.   
 
ABSTRACT     
Human DNA polymerases (pols) η and ι are Y-
family DNA polymerase paralogs that facilitate 
translesion synthesis (TLS) past damaged DNA. 
Both polη and polι can be monoubiquitinated in 
vivo.  Polη has been shown to be ubiquitinated at 
one primary site. When this site is unavailable, 
three nearby lysines, may become ubiquitinated. In 
contrast, mass spectrometry analysis of 
monoubiquitinated polι revealed that it is 
ubiquitinated at over 27 unique sites.  Many of 
these sites are localized in different functional 
domains of the protein, including the catalytic 
polymerase domain, the PCNA-interacting region, 
the Rev1-interacting region, as well as its 
Ubiquitin Binding Motifs, UBM1 and UBM2. Polι 
monoubiquitination remains unchanged after cells 
are exposed to DNA damaging agents such as UV-
light (generating UV-photoproducts), ethyl 
methanesulfonate (generating alkylation damage), 
mitomycin C (generating interstrand crosslinks), 
or potassium bromate (generating direct oxidative 
DNA damage). However, when exposed to 
naphthoquinones, such as menadione and 
plumbagin, which cause indirect oxidative damage 
through mitochondrial dysfunction, polι becomes 
transiently polyubiquitinated via K11- and K48-
linked chains of ubiquitin and subsequently 
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targeted for degradation. Polyubiquitination does 
not occur as a direct result of the perturbation of 
the redox cycle, as no polyubiquitination was 
observed after treatment with rotenone, or 
antimycin A, which inhibit mitochondrial electron 
transport. Interestingly, polyubiquitination was 
observed after the inhibition of the lysine 
acetyltransferase, KATB3/p300.  We hypothesize 
that the formation of polyubiquitination chains 
attached to polι occurs via the interplay between 
lysine acetylation and ubiquitination of ubiquitin 
itself at K11- and K48- rather than oxidative 
damage per se.   
 
 
INTRODUCTION                          
In order to survive the constant threat to their 
genomes from exposure to endogenous and 
exogenous DNA damaging agents, cells are 
equipped with an impressive array of DNA repair 
mechanisms.  Yet situations arise where DNA 
lesions in the genome remain unrepaired and cells 
are forced to tolerate the DNA damage. One such 
tolerance mechanism is “translesion DNA 
synthesis” (TLS)1.  During TLS, the high-fidelity 
replicase, which is unable to traverse the DNA 
lesion due to its constrained active site, is replaced 
with a specialized DNA polymerase (pol) with a 
more spacious active site that can accommodate 
the damaged DNA (1). Many of the DNA 
polymerases discovered in the past fifteen years 
appear to have some capacity to promote TLS.  
However, the best-characterized TLS polymerases 
belong to the Y-family of DNA polymerases (2).  
Y-family DNA polymerases are typified by human 
polη, which bypasses a thymine-thymine 
cyclobutane pyrimidine dimer efficiently and with 
much higher accuracy than any other human TLS 
polymerases (3).  Because of their more spacious 
active sites (4), the TLS enzymes are also able to 
accommodate non-canonical Watson-Crick base 
pairing and are usually much more error-prone 
than high fidelity replicases when they replicate 
undamaged DNA (1). In specialized situations, 
such as during immunoglobulin somatic 
hypermutation, this creates genetic diversity and 
leads to high affinity antigen-specific 
immunoglobulins (5).  However, under normal 
circumstances, random mutagenesis of 
chromosomal DNA is highly deleterious, often 
leading to mutagenesis and tumorigenesis in 
higher organisms.  
 It is clear, therefore, that the activity of the 
TLS polymerases needs to be tightly regulated, so 
that they only gain access to undamaged genomic 
DNA when appropriate. Previous studies have 
revealed that the post-translational modification of 
the TLS polymerases themselves, or their 
interacting partners, play a major role in regulating 
their cellular activities [reviewed in (6)]. In 
particular, both mono- and polyubiquitination 
appear to play a central role in regulating TLS 
polymerases since monoubiquitination of the 
proliferating cell nuclear antigen (PCNA) appears 
to control the switch between high fidelity 
replicases and TLS polymerases (7,8). PCNA can, 
however, be further polyubiquitinated.  The 
addition of K63-linked polyubiquitin chains to 
PCNA that is monoubiquitinated at K164 leads to 
a damage avoidance template-switching pathway 
that in contrast to TLS allows for error-free DNA 
damage bypass (9,10). 
In addition to PCNA, both human polη and 
polι TLS polymerases are also subject to 
monoubiquitination (11,12). Attaching a single 
ubiquitin moiety to one of four lysine residues in 
the C-terminus of polη blocks the physical 
interaction between polη and PCNA (12). As a 
consequence, polη needs to be actively de-
ubiquitinated prior to interacting with PCNA and 
subsequently recruited to a stalled replication fork 
(12). The cellular role of polι monoubiquitination 
remains enigmatic. However, our previous results 
suggest that monoubiquitination of either polη or 
polι is a pre-requisite for the physical and 
functional interaction between the two 
polymerases (13).  
Human polι is one of the least accurate 
DNA polymerases and exhibits a 10,000-fold 
range in base substitution fidelity depending on 
the template sequence copied [reviewed in (1)]. 
Polι has been extensively characterized at the 
biochemical level (14-19), and its in vivo re-
localization in response to DNA damage has been 
shown (20,21). The enzyme is involved in the 
error-free bypass of methylglyoxal-induced minor 
groove lesions, N2-carboxyethyl-2′-
deoxyguanosine (22) and a deficiency in polι has 
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been suggested to cause sensitivity to oxidative 
and 4-hydroxynonenal DNA damage (23,24), as 
well as stimulate UV-induced mesenchymal 
carcinogenesis (25). However, the primary 
biological function of polι is still far from being 
understood. 
Some assumptions on polι’s cellular role can 
be derived from the various domains/motifs 
identified in polι. The N-terminal part of the 
protein contains two partly overlapping catalytic 
domains; a DNA polymerase domain and a dRP-
lyase domain (26,27). The core polymerase 
domain is built of palm, finger, thumb, and little-
finger sub-domains (28,29). The C-terminal 
portion of the protein is unstructured and devoted 
to facilitating interactions with a variety of 
proteins. Similar to other TLS polymerases, polι 
contains a PCNA interacting peptide motif 
responsible for the interaction with PCNA (30-32) 
and a Rev1 interacting region (33,34).  It also 
contains two ubiquitin binding motifs (11).  
Typically, the conjugation of ubiquitin to the 
lysine residue of a substrate protein occurs as a 
result of a three-enzyme cascade process involving 
ubiquitin-activating enzyme (E1), ubiquitin-
conjugating enzyme (E2) and ubiquitin ligase (E3) 
(35). Ubiquitin contains seven lysine residues (K6, 
K11, K27, K29, K33, K48 and K63) and is itself a 
target for further ubiquitination. Indeed, repetitive 
ubiquitination can establish polyubiquitin chains 
on a target protein. The length, the type of linkage, 
and consequent shape of conjugated polyubiquitin 
chains direct the function and processing of many 
intracellular proteins in eukaryotes [reviewed in 
(36)].  All types of ubiquitin chains exist in the 
cell; however, they vary in abundance and 
functionality. Different types of polyubiquitin 
chains regulate different biological processes by 
promoting proteasomal degradation, altering 
subcellular localization, modulating enzymatic 
activity and facilitating protein-protein interactions 
(37). 
In the current work, we have used mass 
spectrometry analysis to identify the lysine 
residues that can be ubiquitinated in human polι. 
In contrast to PCNA, which is primarily 
ubiquitinated at K164 and polη, where the 
ubiquitinated residues are clustered in its C-
terminus, the monoubiquitinated residues in polι 
are scattered amongst its various functional 
domains/motifs. Furthermore, unlike 
monoubiquitinated polη that is de-ubiquitinated 
upon UV-irradiation, the level of 
monoubiquitinated polι remains unchanged after 
exposure to UV, ethyl methanesulfonate, 
mitomycin C, or potassium bromate.  Interestingly, 
however, after exposure to menadione and 
structurally related naphthoquinones polι is 
rapidly polyubiquitinated and intracellular levels 
of both the unmodified and the monoubiquitinated 
forms of polι decrease significantly.  We present 
evidence that polι’s polyubiquitination is not in 
response to oxidative DNA damage per se, but is 
rather due to the inhibition of KAT3B/p300 
dependent acetylation of ubiquitin, which in turn, 
allows for the formation of K11- and K48-linked 
polyubiquitin chains on polι that subsequently 
target it for degradation. 
 
Experimental Procedures 
Reagents - 2,3 dimethoxy-1,4-naphthoquinone 
(DMNQ) was purchased from Enzo Life Sciences 
and ethyl methanesulfonate, mitomycin C, 
potassium bromate, menadione, 1,4-
naphthoquinone, juglone, plumbagin, L002; 
rotenone, antimycin A were all purchased from 
Sigma-Aldrich. 
 
Mammalian expression plasmids - Plasmid 
pJRM46, is a derivative of pCMV6AN-DDK 
(Origene) which expresses N-terminal FLAG-
tagged full-length human polι (13). Derivatives 
with single or multiple K→A, or K→R 
substitutions were generated by chemically 
synthesizing appropriate DNA fragments 
(Genscript) that were subsequently cloned into 
pJRM46. Plasmid pRK7-POLI-3XFLAG, is a 
derivative of pRK7 (38), which expresses full-
length human polι with three C-terminal FLAG-
tags. The vector was constructed by inserting three 
tandem repeats of the FLAG epitope tag 
(DYKDDDDK) into the BamHI and EcoRI sites 
of pRK7 to generate pRK7-3×FLAG. The full-
length human POLI gene was amplified from 
HEK293T cells by reverse transcription PCR 
using primers POLI-S: 
AAAGCTAGCATGGAGAAGCTGGGGGTGGA, 
and POLI-AS: 
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AAAGGATCCTTTATGTCCAATGTGGAAATC
T.  These primers introduce 5' NheI and 3' BamHI 
sites into the amplicon, which was and subcloned 
into the XbaI and BamHI sites of the pRK7-
3XFLAG vector. A full list of plasmids used in the 
current study is shown in Table 1.  
 
Plasmid transfection, protein expression and 
Western blotting – HEK293T cells were plated 
onto 100 mm culture plates at a seeding density of 
3 x 106 cells. When cells were ~40 percent 
confluent, plasmids were transfected into cells 
using Turbofectin 8.0 according to the 
manufacturer’s instructions (Origene). Cells were 
either mock treated, or exposed to a variety of 
agents twenty-four or forty-eight hours after 
transfection depending upon the treatment times 
required. At appropriate times thereafter, cells 
were gently collected, washed twice with cold 
Dulbecco’s PBS without calcium or magnesium, 
and suspended in modified RIPA buffer (25 mM 
Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1 
mM EDTA, 1 mM PMSF, 1 mM Na3VO4 and 
Sigma Protease Inhibitor Cocktail and lysed by 
sonication for 10 seconds. Immediately after 
sonication, the extracts were clarified by 
centrifugation at +4°C for 15 minutes in a Sorvall 
Biofuge Pico at 16,000g. The supernatants 
(extracts) were transferred to fresh tubes and 
protein concentrations were measured using the 
Pierce BCA Assay (Pierce Biotechnology).  Cell 
extracts were kept at +4°C until being separated 
on a 4-16% gradient SDS PAGE gel.  Proteins 
were transferred to a PVDF membrane and FLAG-
tagged polι was visualized using Tropix Western-
Star chemiluminescent kit using mouse anti-FLAG 
monoclonal antibodies (Abnova) followed by 
secondary anti-mouse antibody (Novagen). Where 
noted, other antibodies were used as followed: 
POLI monoclonal antibody (M01), clone 8G9 
(Abnova), or polyclonal rabbit antibodies raised 
against a KLH-conjugated peptide corresponding 
to the C-terminal 15 amino acid residues of polι 
(20). Where noted, the level of polι was compared 
to β-actin present in the extracts, and were 
visualized using rabbit anti-β-actin antibodies 
(Cell Signaling Technologies). The intensity of the 
individual bands was quantified using the ImageJ 
1.47 application (NIH, USA). 
 
Mass spectrometry analysis - Purified 
recombinant N-terminal FLAG-tagged human polι 
was purchased from Origene Technologies 
(Rockville, MD) and was supplied at a final 
concentration of 0.106 mg/ml.  Roughly 80% of 
the total protein represents unmodified FLAG-polι 
and ~10% represents a slower-migrating modified 
FLAG-polι (Fig. 1A).  A total of 5 µg of the 
combined FLAG-polι preparation was applied to a 
1 mm thick precast 10% polyacrylamide NuPage 
gel (Life Technologies).  Proteins were separated 
by SDS-PAGE by running the gel at 190 V for 
3.75 hours.  All subsequent solutions were 
prepared using ultrapure HPLC water. The gel was 
lightly stained using the Novex Collodial Blue 
Staining Kit (Life Technologies), in brand new 
disposable plastic trays.  Unmodified and modified 
FLAG-polι bands were excised using a brand new 
hard-backed razor blade under water. Gel 
fragments were washed 2X with 50% acetonitrile 
in ultrapure water. Samples were sent to the 
Harvard Microchemistry Department (Harvard 
University, MA), where they were analyzed by 
mass spectrometry as a custom contract service. 
 
pRK7-POLI-3XFLAG (1.5 µg) was 
transfected into HEK293T cells (70-80% 
confluence in a 6-well plate) using Lipofectamine 
2000 (Invitrogen). After a 48-hour incubation, the 
C-terminal 3XFLAG-tagged polι protein was 
isolated and purified using anti-FLAG M2 beads 
(Sigma). The purified protein was digested with 
trypsin (Roche) at an enzyme/substrate ratio of 
1:50, and subjected to LC-MS/MS analysis. 
LC-MS/MS experiments were performed as 
described previously (39). Briefly, the peptides 
were separated on an EASY-nLC II and analyzed 
on an LTQ Orbitrap Velos mass spectrometer 
equipped with a nanoelectrospray ionization 
source (Thermo). The trapping column (150 µm × 
50 mm) and separation column (75 µm × 120 mm) 
were packed with ReproSil-Pur C18-AQ resin (3 
µm in particle size, Dr. Maisch HPLC GmbH, 
Germany). The peptide samples were firstly 
loaded onto the trapping column in CH3CN/H2O 
(2:98, v/v) at a flow rate of 4.0 µl/min, and 
resolved on the separation column with a 120-min 
linear gradient of 2-40% acetonitrile in 0.1% 
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formic acid and at a flow rate of 300 nl/min. The 
LTQ-Orbitrap Velos mass spectrometer was 
operated in the positive-ion mode, and the spray 
voltage was 1.8 kV. The full-scan mass spectra 
(m/z 300-2000) were acquired with a resolution of 
60,000 at m/z 400 after accumulation to a target 
value of 500,000 in the linear ion trap. MS/MS 
data were obtained in a data-dependent scan mode 
where one full MS scan was followed with 20 
MS/MS scans.  
 
Results 
Sites of ubiquitination in polι - It has been 
previously reported that polι is monoubiquitinated 
in vivo (11).  However, at the time that we 
embarked on these studies, the location of the 
modified residue(s) had yet to be determined. To 
identify the site(s) of ubiquitination in polι we 
initially utilized the contract services of the 
Harvard Microchemistry Department (Harvard 
University) to provide mass spectrometry analysis 
of a commercially available preparation of N-
terminal FLAG-tagged human polι (Origene) (Fig. 
1A).  The preparation contains a significant 
amount of a slower migrating protein that cross-
reacts with anti-FLAG antibodies, as well as both 
polyclonal and monoclonal antibodies against polι 
(Fig.1B).  Based upon the earlier work of Bienko 
et al. (11), we hypothesized that the slower 
migrating band was likely to be monoubiquitinated 
polι. 
Mass spectrometry analysis of the isolated 
slower-migrating FLAG-polι protein indicated it 
was indeed monoubiquitinated polι, which was 
modified at six unique lysine residues (K248, 
K522, K526, K530, K549 and K704). Although 
we had limited mass spectrometry coverage of the 
very C-terminus of polι, we rationalized that the 
C-terminal K715 residue might also be subject to 
ubiquitination, since it is most probably localized 
on the surface of the protein and thus likely to be 
exposed to ubiquitinating enzymes.  
To determine which of the residues might be 
the primary site of polι ubiquitination, we 
transfected human HEK293T cells with a series of 
recombinant plasmids carrying FLAG-tagged polι 
each containing a single lysine to alanine 
substitution (K248A, K522A, K526A, K530A, 
K549A, K704A and K715A) and checked the 
extent of polι ubiquitination by western blotting 
and probing with anti-FLAG antibodies. 
Remarkably most of the polι mutants were 
ubiquitinated at levels comparable to the wild-type 
protein (Fig. 2A). Interestingly, the largest 
reduction in ubiquitination occurred in the K715A 
mutant, which exhibited approximately 60% of the 
level observed with the wild-type protein, 
indicating that K715 is indeed a target for 
ubiquitination. Based on these observations, it 
appears that none of the seven lysines is an 
exclusive site of ubiquitination.  However, we 
rationalized that modification at lysines in close 
proximity to the respective alanine substitution, 
might mask the effect of individual lysine 
mutations (e.g., K522, K526 and K530). To test 
this hypothesis, we determined the extent of 
ubiquitination of polι mutants containing multiple 
K→A substitutions.  This included double 
(K704A/K715A), quadruple (K522A/ K526A/ 
K530A/ K549A), and even septuple (K248A/ 
K522A/ K526A/ K530A/ K549A/ K704A/ 
K715A) substitutions (Fig. 2B). To our surprise, 
ubiquitination of polι in the septuple mutant was 
only diminished by ~50% compared to the wild-
type protein suggesting the existence of additional 
ubiquitination sites in polι. By analogy to polη, 
where a K682A substitution leads to ubiquitination 
at nearby lysine residues (12), we made K→A 
substitutions at polι residues K237, K245 and 
K550. Based on the results obtained by Wagner et 
al. (40), who reported proteome-wide analysis of 
in vivo ubiquitination sites, we also made K→A 
substitutions at K267 and K271. However, a 
duodecuple mutant carrying all 12K→A 
substitutions did not prevent monoubiquitination 
of polι (Fig. 2B), thereby implying additional sites 
of ubiquitination in polι. 
 We therefore undertook an independent 
mass spectrometry analysis approach, this time 
using C-terminal FLAG-tagged polι.  Interestingly, 
we identified six ubiquitination sites in polι that 
were clustered in the N-terminal half of the 
polymerase (K53, K283, K309, K271, K310 and 
K320).  None of these sites emerged in the original 
analysis of N-terminal FLAG tagged polι 
performed at the Harvard Microchemistry 
department and only one residue (K271), was 
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identified in the earlier studies by Wagner et al. 
(40).   
Thus, by three independent approaches, two 
specifically focused on polι (described herein) and 
one proteome-wide (Wagner et al.), seventeen 
independent ubiquitination sites in polι were 
identified. We were interested in determining if 
substitutions at these sites would finally block 
ubiquitination of polι. Given the close structural 
proximity of polι K51 and K72 residues to K53 
(29), we also made substitutions at these residues.  
The combined mutant has 19K→A substitutions. 
We noted that this mutant has altered gel 
electrophoretic mobility (Fig. 3A) and decided to 
limit the influence of the multiple alanine 
substitutions on the global charge of the protein 
and consequently its structure, so we also 
generated a 19K→R mutant.  
Interestingly, the 19K→A mutant showed 
60% higher levels of polι ubiquitination than the 
19K→R mutant (Fig. 3), suggesting that multiple 
K→A mutations probably changed the structure of 
polι and possibly exposed lysine residues that 
perhaps would not normally be subject to 
monoubiquitination. We also observed the same 
effect when comparing the 12K→A to the 
12K→R mutants.  In light of the fact that the 
K→R changes in the combined polι mutants 
reduced ubiquitination of polι more acutely than 
the K→A mutations, we decided to re-evaluate the 
effect of a single K715R substitution, since the 
K715A mutant gave the greatest reduction in the 
levels of ubiquitination (Fig. 2).  Again, the 
conservative K715R substitution diminished 
ubiquitination of polι to a greater extent than 
K715A.  In some regards, this is surprising, since 
one might expect that the extreme C-terminal 
residue would be exposed and there would not be 
a large structural effect of the alanine, or arginine 
substitutions. 
Recent technical progress in mass 
spectrometry-based methods in combination with 
novel ubiquitin enrichment strategies using di-
Gly-lysine specific antibody (41) have 
significantly increased the number of documented 
ubiquitinated proteins and pinpointed many of 
their ubiquitin-modified lysines on a global level, 
including many TLS proteins (6). Within the last 
four years, several groups have reported large-
scale detection of lysine ubiquitination events in 
human cells and in nine of these studies 
ubiquitination sites of polι have been identified 
(41-49).  
Figure 4 summarizes all the lysine residues 
in polι that have been shown to be ubiquitinated. 
In total, 27 lysine residues of polι have been 
experimentally shown to be ubiquitinated.  Based 
upon structural considerations, we have identified 
another three lysine residues that could potentially 
be ubiquitinated. Eight of the sites were detected 
just once. The remaining 19 ubiquitination sites in 
polι were identified in anywhere between 2 to 6 
independent studies, often using very different 
experimental strategies (e.g., ectopically expressed 
vs. chromosomally expressed polι and/or different 
detection methods).  However, no single site has 
been identified in all of the PTM studies.  Thus, 
unlike polη, which is ubiquitinated at one primary 
site and a handful of secondary sites (12), polι 
does not appear to possess a primary site for 
ubiquitination, but is, instead, ubiquitinated at 
multiple lysine residues. 
Polι ubiquitination in response to a variety of 
DNA damaging agents - The 30 potential 
ubiquitination sites are distributed along the entire 
length of the polι peptide.  However, some are 
clustered in domains and motifs of polι that are 
important for its cellular function in DNA damage 
tolerance (dRP lyase domain, catalytic polymerase 
domain, PIP, RIR, UBM1 and UBM2) (Fig. 4). 
We were therefore interested in determining if the 
ubiquitination status of polι is influenced by 
exposure to DNA damaging agents. Indeed, there 
is a precedent for damage-induced de-
ubiquitination of human polη, so as to allow it to 
interact with ubiquitinated PCNA and facilitate 
TLS (12).  We therefore examined polι 
ubiquitination in response to treatment with agents 
that cause different types of DNA damage such as 
UV irradiation which results in both cyclobutane 
pyrimidine dimers and 6-4 photoproducts; ethyl 
methanesulfonate which generates alkylation 
damage (50); mitomycin C which generates 
interstrand crosslinks (51,52); and two oxidizing 
agents, potassium bromate and menadione (53,54). 
Somewhat surprisingly, most of the DNA 
damaging agents did not result in any significant 
change in the extent of polι ubiquitination, even 
 at IN
STY
TU
T BIO
CH
EM
II I BIO
FIZY
K
I on O
ctober 12, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Ubiquitination of polι 	  
	   7	  
several hours after the initial treatment (Fig. 5A-
D). In contrast, in cells treated with 30 µM 
menadione for one hour (time 0), we observed an 
increase of polι with much slower mobility, that is 
consistent with polyubiquitination of polι (Fig. 
5E). Furthermore, the intracellular levels of polι 
decrease significantly 3-5 hours after treatment, 
suggesting that the posttranslationally modified 
polι protein is targeted for degradation.   
Polι ubiquitination in response to treatment 
with various naphthoquinones and inhibitors of 
mitochondrial function - Our observation that 
potassium bromate did not elicit the same 
polyubiquitination of polι as menadione, suggests 
that polyubiquitination of polι is unlikely to occur 
as a result of oxidative damage per se, but occurs 
in specific response to menadione treatment.  
While both agents cause oxidative DNA damage, 
they do so by different mechanisms. For example, 
potassium bromate induces glutathione-mediated 
oxidative base damage (53), whereas menadione 
does so by inducing mitochondrial dysfunction, 
leading to an increase in reactive oxygen species 
(ROS) (54).  However, we observed no significant 
increase in polι polyubiquitination after inhibition 
of the mitochondrial respiratory chain complex I 
with rotenone (55), or antimycin A, which inhibits 
cytochrome C reductase and the production of 
ATP (56) (Fig. 6), indicating that simple 
mitochondrial dysfunction is not the root cause for 
polι polyubiquitination.   
In contrast, we discovered that polι 
polyubiquitination occurs after exposure to 
naphthoquinones that are structurally related to 
menadione (Fig. 7), including 1,4-naphthoquinone, 
juglone and plumbagin.  Similar to menadione, all 
three compounds stimulated polι 
polyubiquitination in a concentration-dependent 
manner (Fig. 7).  A particularly strong effect was 
observed after exposure to low concentrations of 
juglone and plumbagin (Fig. 7C & D).   However, 
another naphthoquinone, 2,3 dimethoxy-1,4-
naphthoquinone (DMNQ) that also causes 
significant oxidative DNA damage (57) did not 
induce polι polyubiquitination (Fig. 8).  Although 
the UV-induced ubiquitination/deubiquitination of 
polη and polι seem to be differentially regulated 
(c.f., (12) and Fig 5A), pol η also appears to 
undergo polyubiquitination in response to 
menadione, and plumbagin treatment (unpublished 
observations).  Whether this occurs as a result of a 
common pathway controlling the 
polyubiquitination of both polymerases in 
response to naphthoquinones remains to be 
determined. 
Polι ubiquitination in response to treatment 
with an inhibitor of KAT3B/p300 - It is apparent 
that the effects of menadione, juglone, 1,4 
naphthoquinone and plumbagin cannot be simply 
attributed to oxidative DNA damage, or 
mitochondrial dysfunction.  However, 
naphthoquinones are also known to inhibit the 
activity of the lysine acetyltransferase 
KAT3B/p300 (58,59).  We therefore considered 
the possibility that the inhibition of ubiquitin 
acetylation may promote the polyubiquitination of 
polι.  To test this hypothesis, HEK293T cells were 
treated with the KAT3B/p300 inhibitor, L002.  
Indeed, similar to the effects of naphthoquinones, 
L002 results in the polyubiquitination of polι (Fig. 
7E).  
Mass spectrometry analysis of 
polyubiquitinated forms of polι - To further 
explore the nature of polyubiquitinated forms of 
polι appearing after treatment with 
naphthoquinones, we performed mass 
spectrometry analysis on the purified ubiquitin-
conjugated polι. To do so, we used M2 anti-FLAG 
beads (Sigma) to pull-down N-terminal FLAG-
tagged polι expressed in HEK293T cells that had 
been treated for 1 hour with 30 µM menadione 
(Fig. 7A), followed by tryptic digestion and LC-
MS/MS analysis. This analysis was repeated twice, 
with independently prepared extracts and extracts 
from non-treated cells were used as controls. In 
control experiments, we predominantly observed 
monoubiquitinated forms of polι. In these extracts, 
we identified 7 ubiquitinated lysines (K87, K271, 
K283, K309, K486, K488 and K508). All of them 
except K508 were known as potential 
ubiquitination sites from previous approaches. 
Interestingly, in extracts prepared from 
menadione-treated cells, where intensive 
polyubiquitination of polι was observed, we 
identified four ubiquitinated lysines (K271, K309, 
K320 and K488) located in the N-terminal and 
central part of polι. Three of them, K271, K309 
and K488, were identified in both independent 
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experiments. Since all four residues were 
previously indicated in our earlier experiments, or 
in proteome-wide experiments (40,42,43,46,47), 
as potential ubiquitination sites in untreated cells, 
we conclude that menadione treatment most 
probably causes polyubiquitination of polι at 
lysine residues that are already monoubiquitinated, 
rather than de novo at novel lysines. 
In polyubiquitin chains, ubiquitins are linked 
to each other via an isopeptide bond between the 
C-terminal glycine of one ubiquitin and one of the 
lysine residues of the next ubiquitin. Ubiquitin 
contains seven lysine residues (K6, K11, K27, 
K29, K33, K48 and K63) and all of them can 
become ubiquitinated to establish polyubiquitin 
chains of different shape and biological function 
[reviewed in (36)].  Mass spectrometry analysis of 
polyubiquitinated polι revealed that the 
polyubiquitin chains formed in response to 
menadione are formed via K11- and K48-linkages 
(Fig. 9B & 9C).  Aside from these two peptides 
carrying a diglycine remnant, we also observed 
unmodified tryptic peptides derived from ubiquitin, 
including TLSDYNIQK (amino acid residues 55-
63) and TITLEVEPSDTIENVK (amino acids 
residues 12-27). Moreover, we observed K11- and 
K48- linkages in polyubiquitinated polι obtained 
from plumbagin treated cells (unpublished 
observations). Presumably these linkages are 
formed in response to a common signal induced by 
exposure to naphthoquinones. 
K48-linked polyubiquitin chains represent 
one of the most known and abundant ubiquitin 
linkages in the cell and target marked proteins to 
degradation by the 26S proteasome (60,61). The 
cellular role of the K11-linkage is less known, 
however the function of homogenous K11-linked 
polyubiquitin chains are also implicated in 
proteasomal degradation (62,63). Consistent with 
the notion that polyubiquitinated polι is subject to 
proteasomal degradation, we observed an increase 
in the background levels of polyubiquitinated polι 
in undamaged cells in the presence of the 
proteasome inhibitor, MG132 (Fig. 10). 
 
Discussion 
Ubiquitination is an important factor allowing 
for quick, controlled and reversible modification 
of a protein’s fate, cellular abundance, function, 
localization, and the promotion of protein-protein 
interactions. Several proteins employed in TLS are 
known to be ubiquitinated in vivo and the protein 
modification is used to adjust the specificity of 
TLS mechanisms in a variety of ways [reviewed in 
(6)].  
It has been a decade since the discovery that 
human polι can be monoubiquitinated in vivo (11), 
yet the consequences of the modification remains 
enigmatic. Our previous studies, which show the 
dependence of a polι-polη interaction on the 
ubiquitination of either protein (13) provides some 
early insights into a possible role of polι 
modification.  
In the present study, we have identified a 
number of lysine residues in polι that can be 
covalently linked to ubiquitin.  Unlike polη, which 
is ubiquitinated at one primary site and a handful 
of secondary sites (6,12), we discovered that polι 
is ubiquitinated at more than 27 unique sites (Fig. 
4). Two thirds of the identified sites were detected 
in multiple autonomous studies using different 
experimental strategies (e.g., ectopic expression of 
N- and C-terminal FLAG tagged polι vs. native 
untagged chromosomally expressed polι and 
different methods of identification). While we 
cannot exclude the possibility that polι is 
ubiquitinated at random sites, we believe that the 
detection of specific ubiquitination sites in 
multiple independent studies increases the 
probability that those sites are likely to play key 
roles in regulating the cellular activities of polι. 
When assayed by SDS-PAGE, the 
predominant form of polι is a single mono-
ubiquitinated species, rather than multiply mono-
ubiquitinated forms of polι.  We note that under 
certain conditions, such as when cells are exposed 
to menadione, we do observe a “laddering” of 
FLAG-tagged polι, indicative of multiple 
monoubiquitination events (Fig. 7), but we cannot 
distinguish between the possibility of multiple 
monoubiquitinations of polι, or a single 
monoubiquitination event that is subsequently 
converted into a polyubiquitin chain.  Our 
observations therefore indicate that once polι is 
monoubiquitinated at one particular site, it 
subsequently precludes monoubiquitination at 
additional sites in polι.  Clearly, this is an area of 
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research that needs to be studied in detail and will 
be the subject of future studies. 
No single K→A, or K→R substitution 
completely blocked monoubiquitination of polι.  
However a K→R substitution at K715 which is 
located at the very C-terminus of polι and which 
has been shown to be ubiquitinated in two 
independent proteome-wide approaches (43,49), 
gave the greatest reduction in monoubiquitination 
(Fig. 3).  We predict that the structure of 
covalently-linked ubiquitin to K715 will position 
the ubiquitin moiety for a productive interaction 
with the UBM2 of polι (Fig. 11E).  Similarly, 
ubiquitination at K522 may also facilitate an 
interaction between ubiquitin and UBM1 of polι 
(Fig. 11D).  We hypothesize that such interactions 
may, in turn, help promote an interaction between 
polι and polη (13). 
 In contrast, monoubiquitination of other 
lysine residues may have a detrimental effect on 
polι’s cellular functions. For example, many sites 
are located in the catalytic domain of the 
polymerase and may alter both DNA binding 
properties and polymerase activity of polι (Fig. 4, 
11A and Table 2).  Ubiquitination sites were also 
identified in both the PIP-box (PCNA-interacting 
region) and the RIR motif (Rev1-interacting 
region) and it seems highly unlikely that polι 
would be able to physically interact with either 
PCNA, or Rev1, if these sites are ubiquitinated 
(Fig. 11B & 11C).  
Unlike polη, which is de-ubiquitinated upon 
UV-irradiation (12), the level of polι 
monoubiquitination remained constant after 
exposure to a variety of DNA damaging agents 
including UV-light, EMS, MMC, or the oxidative 
DNA damage inducers, potassium bromate (Fig. 
5), rotenone and antimycin A (Fig. 6) and DMNQ, 
(Fig. 8).   In dramatic contrast, menadione and 
several structurally related naphthoquinones, 
resulted in the rapid polyubiquitination of polι.  
Mass spectrometry of polyubiquitinated polι 
purified from menadione- and plumbagin-treated 
cells indicated that the polyubiquitin chains were 
formed through K11- and K48- linkages. 
Conjugation of ubiquitin via K48-linkage is well 
known to serve as a signal for proteasomal 
degradation (60,61). Indeed, the disappearance of 
polι 3-5 hours after exposure to menadione (Fig. 
5E) is consistent with its degradation. 
We initially considered that the signal 
triggering polyubiquitination of polι might be 
oxidative DNA damage, but this was rapidly 
excluded when we failed to observe 
polyubiquitination in response to potassium 
bromate (Fig. 5C), DMNQ (Fig. 8), rotenone, or 
antimycin A (Fig. 6). However, in addition to the 
induction of reactive oxygen species, the 
naphthoquinones are also known to exert a wide 
range of cellular effects leading to stress signaling, 
anti-angiogenesis and thiolate arylation of proteins 
and amines (64-66). One property of interest is 
their ability to inhibit the lysine acetyltransferase 
(KAT), p300 (58,59). All of the naphthoquinones 
(1,4-naphthoquinone, menadione, juglone, 
plumbagin) that induce polι polyubiquitination 
have previously been reported to inhibit the KAT 
activity of p300 (59). It is unknown whether 
DMNQ (which did not cause polι 
polyubiquitination), can inhibit the KAT activity 
of p300.  However, since DMNQ lacks the critical 
hydroxyl group at the 5th position of the benzene 
ring that is required for inhibition of KAT activity 
(59) and the 2nd and 3rd positions that are normally 
subject to nucleophilic attack are occupied by 
methoxy groups (Fig. 8), we assume that it 
probably does not inhibit KAT activity,  
It is now well established that acetylation is a 
key regulator of diverse biological processes, from 
metabolism to signaling and immunity (67). 
Indeed, like many proteins, ubiquitin is subject to 
acetylation (49,68).  Interestingly, both K11- and 
K48- are moderately sensitive to acetylation 
(49,68). Thus, we hypothesize that if K11- and 
K48- of ubiquitin are acetylated, it would preclude 
the formation of polyubiquitin chains via these 
linkages. Our observation that the p300 inhibitor, 
L002, also induces polyubiquitination of polι 
strongly suggests that there is a competition 
between ubiquitination and acetylation at 
overlapping lysine residues in polι. We believe 
that such competition constitutes a novel 
mechanism to regulate the stability of polι that 
warrants further investigation. 
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FIGURE LEGENDS 
 
FIGURE 1.  Highly purified polι  protein, purchased from Origene Technologies.  A,  Commassie 
Brilliant Blue stained gel of FLAG-tagged polι purified from HEK293T cells.  B, Western blot of purified 
polι. Polι was visualized using monoclonal antibodies to the FLAG epitope (track 1); polyclonal 
antibodies to polι (track 2); or monoclonal antibodies to polι (track 3).  The images clearly show that the 
major band observed in the Coomassie Brilliant Blue stained gel corresponds to native FLAG-polι. The 
slower migrating band also contains polι and appears to be a posttranslationally modified form of polι.  
The faster migrating band observed in panel A, does not appear to be related to FLAG-polι since it does 
not cross-react to either the FLAG or polι antibodies. 
 
FIGURE 2.  Effects of K→A substitutions on the extent of polι  ubiquitination in HEK293T cells.  A, 
Single amino acid substitutions.  B, Multiple amino acid substitutions. 2K, (K704A/ K715A); 4K, 
(K522A/ K526A/K530A/ K549A); 7K (K248A/ K522A/ K526A/ K530A/ K549A/ K704A/ K715A); 12K, 
(K237A/ K245A/ K248A/ K267A/ K271A/ K522A/ K526A/ K530A/ K549A/ K550A/ K704A/ K715A).  
Upper panel; a representative western blot using monoclonal anti-FLAG antibodies.  Lower panel; 
densitometric quantification of polι monoubiquitination. Data are the mean values from six (A) or three 
(B) independent experiments, ±SD. 
 
FIGURE 3.  Effects of K→A and K→R substitutions on the extent of ubiquitination of polι  in 
HEK293T cells. A, Western blot using monoclonal anti-FLAG antibodies. B, Lower panel; densitometric 
quantification of polι monoubiquitination. Data are the mean values from four to five independent 
experiments, ±SD. Lysine residues were changed to either alanine or arginine.  19K; (K51/ K53/ K72/ 
K237/ K245/ K248/ K267A/ K271A/ K283/ K309/ K310/ K320/ K522/ K526/ K530/ K549/ K550/ K704/ 
K715); 12K, (K237/ K245/ K248/ K267/ K271/ K522/ K526/ K530/ K549/ K550/ K704/ K715); and the 
C-terminal K715 residue. 
 
FIGURE 4.  Sites of ubiquitination in polι .  Lysine residues in polι  that have been shown to be 
subject to ubiquitination are indicated with a colored dot.  The reference for each residue is given 
below the primary amino acid sequence of polι.  As noted, polι can be ubiquitinated at more than 27 
unique lysine residues.  Some residues have been observed in multiple studies, but no single residue has 
been identified in every study.  The various motifs and domains in polι are identified by color-coded bars 
above the primary amino acid sequence. 
 
FIGURE 5.  Effect of DNA damaging agents on the extent of polι  ubiquitination in HEK293T cells.  
A, UV-irradiation (resulting in cyclobutane pyrimidine dimers and 6-4 photoproducts); B, EMS (resulting 
in alkylation DNA damage); C, MMC (resulting in interstrand crosslinks); D, Potassium bromate 
(resulting in oxidative DNA damage) E, Menadione (believed to cause oxidative damage and a variety of 
other cellular effects).  Polι was visualized in western blots using monoclonal antibodies to the N-terminal 
FLAG epitope.  The major band is unmodified polι, followed by mono-ubiquitinated polι.  Slower 
migrating proteins are believed to be polyubiquitinated forms of polι. 
 
FIGURE 6.  Effect of rotenone or antimycin A on polι  ubiquitination in HEK293T cells.  Cells were 
treated with the indicated amount of either rotenone, or antimycin A for 1 hr prior to harvesting. Polι was 
visualized in western blots using monoclonal antibodies to the N-terminal FLAG epitope.  The major 
band is unmodified polι, followed by mono-ubiquitinated polι.  Under these conditions, there was no 
significant induction of polyubiquitinated polι. 
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FIGURE 7.  Effect of various naphthoquinones and a lysine acetyltransferase inhibitor, L002, on the 
extent of polι  polyubiquitination in HEK293T cells.  Cells were treated for 1 hr with the indicated 
concentration of each compound. A, menadione; B, 1,4 naphthoquinone; C, juglone; D, plumbagin; E, 
L002.  Polι was visualized in western blots using monoclonal antibodies to the N-terminal FLAG epitope.   
All compounds lead to an increase in polyubiquitinated forms of polι, with the most dramatic effects 
observed with the naturally occurring naphthoquinone, plumbagin.  The chemical structures of each 
compound are shown on the right-hand side of each panel. 
 
FIGURE 8.  Comparison of menadione, or DMNQ treatment on polι  ubiquitination in HEK293T 
cells.  Cells were treated with the indicated amount of either mendione, or DMNQ for 1 hr prior to 
harvesting. Polι was visualized in western blots using monoclonal antibodies to the N-terminal FLAG 
epitope.  The panel depicting polι ubiquitination after menadione treatment is a slightly darker exposure 
of Fig. 7A, so as to highlight the laddering of the ubiquitinated forms of polι (as noted by arrowheads). 
Under these conditions, there was no significant induction of polyubiquitinated polι after treatment with 
DMNQ. 
 
FIGURE 9.  Mass spectrometry analysis of ubiquitinated polι  recovered from menadione–treated 
HEK293T cells. A, Western blot of purified proteins recovered from untreated and menadione–treated 
cells.  Note that the menadione-treated cell extract contains significantly more polyubiquitinated forms of 
polι than the untreated cell extract.  Both extracts were subjected to mass spectrometry analysis. B, The 
MS/MS of the [M+2H]2+ ion of the peptide 43LIFAGKubiQLEDGR54 from menadione-treated polι 
samples showing the K48-linkage of ubiquitin.  C, The MS/MS of the [M+2H]2+ ion of the peptide 
7TLTGKubiTITLEVEPSDTIENVK27 from menadione-treated polι samples showing the K11-linkage of 
ubiquitin. ‘ubi’, ubiqutination. 
 
FIGURE 10.  Effect of the proteasomal inhibitor MG132, on polι  ubiquitination in HEK293T cells.  
Cells were either untreated, or exposed to the proteasomal inhibitor, MG132, for the times indicated. Polι 
was visualized in western blots using monoclonal antibodies to the N-terminal FLAG epitope.  In both 
cases, the major band is unmodified polι, followed by monoubiquitinated polι.  We note that the intensity 
of polyubiquitinated polι increases over time, in the MG132 treated cells compared to untreated cells, 
suggesting that the basal level of polyubiquitinated polι is normally kept to a minimum by 26S 
proteasomal degradation.  
 
FIGURE 11.  Diagram of ubiquitinated lysine residues in the three-dimensional structures of human 
polι . A, The catalytic domain of human polι (1-420 amino acids) is shown in a ternary complex with 
DNA (purple tube-and-ladder) and an incoming dGTP (PDB: 3GV8) (29). The polι regions are always 
shown as a yellow cartoon with the lysine located near the functional interface highlighted as a dark blue 
stick. The lysines that are distal from a functional surface are shown in light blue. K320, whose 
ubiquitination may destabilize the protein structure, is shown in orange. Some lysine side chains are 
disordered and are thus modeled as alanine (K51, K83, K283 and K310). B, The PIP region of human polι. 
K421 is near the interface with the green subunit of the trimeric PCNA (the other two PCNA subunits are 
shown in pink and cyan behind the green subunit) according to the crystal structure (PDB: 2ZVM) (69). C, 
The RIR of human polι is modeled after the crystal structures of human and mouse polκ in a complex 
with REV1/3/7 (PDB: 4GK5 and 4FJO, respectively). Two lysine residues of the RIR (K549-K550) are 
conserved, but only one (K550), is near the interface with REV3 and forms a salt bridge with a conserved 
glutamate of REV1 (E1174 in human REV1). D, The UBM1 of human polι is modeled after the NMR 
structure of mouse UBM1 in a complex with ubiquitin (PDB: 2KWV) (70). K522 is hydrogen bonded 
with the main chain carbonyl oxygen of L71 in ubiquitin. E, UBM2 of human polι in complex with 
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ubiquitin is shown according to the NMR structure (PDB: 2L0F) (71). K715, the C-terminal residue of 
polι is near the interface with ubiquitin, while K697 and K704 are distal from ubiquitin. 
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Table 1:  Plasmids used in this study 
Plasmid  Description      Source 
pJRM46  pCMV6AN-DDK-polι (N-terminal tag)   (13) 
 
pRK7-POLI-3XFLAG pRK7-3xFLAG-polι (C-terminal tag)   this work 
 
pJRM57  pCMV6AN-DDK-polι_K248A    this work 
 
pJRM48  pCMV6AN-DDK-polι_K522A    this work 
 
pJRM49  pCMV6AN-DDK-polι_K526A    this work 
 
pJRM50  pCMV6AN-DDK-polι_K530A    this work 
 
pJRM51  pCMV6AN-DDK-polι_K549    this work  
 
pJRM52  pCMV6AN-DDK-polι_K704A    this work  
 
pJRM53  pCMV6AN-DDK-polι_K715A    this work 
 
pJRM226  pCMV6AN-DDK-polι_K715R    this work 
 
pJRM54  pCMV6AN-DDK-polι_K704A/K715A    this work  
 
pJRM55  pCMV6AN-DDK-polι_K522A/K526A/    this work  
K530A/K549A 
 
pJRM89  pCMV6AN-DDK-polι_K248A/K522A/    this work  
K526A/K530A/K549A/K704A/K715A 
 
pJRM106  pCMV6AN-DDK-polι_K237A/K245A/K248A/  this work 
K267A/K271A/K522A/K526A/K530A/K549A/ 
K550A/K704A/K715A 
 
pJRM219  pCMV6AN-DDK-polι_K237R/K245R/K248R/  this work 
K267R/K271R/K522R/K526R/K530R/K549R/ 
K550R/K704R/K715R 
 
pJRM193  pCMV6AN-DDK-polι_K51A/K53A/K72A/  this work 
K237A/K245A/K248A/K267A/K271A/K283A/ 
K309A/K310A/K320A/K522A/K526A/K530A/ 
K549A/K550A/ K704A/K715A  
 
pJRM192  pCMV6AN-DDK-polι_K51R/K53R/K72R/  this work 
K237R/K245R/K248R/K267R/ K271R/K283R/ 
K309R/K310R/K320R/K522R/K526R/K530R/ 
K549R/K550R/ K704R/K715R 
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Table 2:  Location of ubiquitination sites in polι and their structural implicationsa  
 
A: Polymerase Domain 
K51: located in the finger domain, pointing towards the outside of the protein 
K53: located in the finger domain, pointing towards the outside of the protein 
K72: located in the finger domain, pointing towards the outside of the protein 
K87: located in the finger domain, ~20Å from the incoming nucleotide, may have some effect on 
catalysis 
K138: on the rear side of the protein, when looking at the active site of the polymerase 
K203: likely to effect DNA binding and overall structure of the polymerase 
K237: likely to effect DNA binding 
K245: likely to effect DNA binding 
K248: likely to effect DNA binding 
K267: on the rear side of the protein, when looking at the active site of the polymerase 
K271: ~ 15Å from the upstream DNA duplex, may have some effect on catalysis 
K283: on the rear side of the protein, when looking at the active site of the polymerase 
K309: may be involved in DNA binding, as it is ~8 Å from the downstream ssDNA 
K310: on the same face as DNA binding, but distal from DNA 
K320: near D306 and E323 for the structure stability and near the finger domain 
K389: on the same face of DNA binding, but distal from DNA 
 
B. PCNA interaction motif  
K421: near the PCNA interface 
 
C. UBM1  
K508: conserved in mouse (K506) and pointing away from the ubiquitin interface, 
K522: conserved in mouse (K520), forming a H-bond with ubiquitin  
K526: not conserved in mouse UBM1, N524 of mouse polι points away from the ubiquitin interface 
K530: not in the mouse UBM1 structure 
 
D. Rev1 Interacting Region 
K549: pointing away from the interface with Rev1 
K550: close to the surface of Rev1  
 
E. UBM2   
K697: pointing away from ubiquitin 
K704: pointing away from ubiquitin 
K715: C-terminal residue, not in UBM2 per se, but conjugation at this residue would likely position 
ubiquitin for a non-covalent interaction with UBM2. 
 
a: See Figure 11 
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